SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001654954-20-007107
Filing Date
2020-06-29
Accepted
2020-06-29 18:34:34
Documents
85
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT vtgn10k_mar312020.htm 10-K 2833472
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ex-231.htm EX-23.1 4335
3 CERTIFICATION ex-311.htm EX-31.1 12933
4 CERTIFICATION ex-312.htm EX-31.2 13052
5 CERTIFICATION ex-32.htm EX-32 6452
6 IMAGE a94b1.jpg GRAPHIC 41509
7 IMAGE a94b2.jpg GRAPHIC 32907
8 IMAGE ph10phase2amdd.jpg GRAPHIC 46849
9 IMAGE productpipeline.jpg GRAPHIC 57707
  Complete submission text file 0001654954-20-007107.txt   7167607

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT vtgn-20200331.xml EX-101.INS 1088774
11 XBRL TAXONOMY EXTENSION SCHEMA vtgn-20200331.xsd EX-101.SCH 58698
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vtgn-20200331_cal.xml EX-101.CAL 58815
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtgn-20200331_def.xml EX-101.DEF 129484
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtgn-20200331_lab.xml EX-101.LAB 306189
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtgn-20200331_pre.xml EX-101.PRE 270208
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 001-37761 | Film No.: 20998542
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences